| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9364975 | Current Diagnostic Pathology | 2005 | 9 Pages |
Abstract
Malignant cells, both mesothelioma and metastases, can be difficult to distinguish from reactive benign mesothelial cells. Careful attention must be paid to the morphology of the questionable cells as well as any background inflammation and pertinent clinical history. Various diagnostic adjuncts have been investigated, particularly immunocytochemistry, but with no firm consensus regarding an optimal approach to resolving difficult cases. This review examines the morphology, immunocytochemistry and future directions of effusion cytology.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Robert L. Zimmerman,